The institute focuses on severe neurological trauma and degenerative conditions including Chronic Traumatic Encephalopathy (CTE), traumatic brain injury (TBI), post-concussive syndrome, spinal cord injury, Alzheimer's disease, ALS, major depressive disorder, PTSD, and alcohol-induced brain damage.
Patients may access the Matthew Protocol™ through participation in clinical trials and observational registries conducted in partnership with Cedars-Sinai. The program is provided at no cost to qualifying low-income or disadvantaged individuals.
Yes, the institute offers specialized outreach, education, and navigation assistance for military veterans with neurological injuries, including help with disability claims and connection to compassionate healthcare providers.
All consultations and educational materials are provided free of charge to patients, caregivers, and the public to promote accessible understanding of neurological conditions and treatment options.
The Patriot Institute uses a proprietary AI-enabled PRC-Forms© platform that is HIPAA-compliant and designed to meet modern FDA data management standards, ensuring secure, accurate, and confidential handling of patient information.
Re-Built-Like-This™ produces inspirational athletic apparel, with 100% of net profits funding the institute's research, patient support services, and veteran community programs.
The institute provides handled transportation services through a dedicated Director of Transportation, assisting patients door-to-door, including hospital navigation and airport pick-ups, to reduce logistical barriers to care.
Yes, caregivers receive clear, jargon-free educational resources and 24/7 access to support services to help them understand neurological injuries and assist their loved ones effectively.
The institute partners with neurologists, neuro-oncologists, and other clinicians to design and implement FDA-compliant clinical trials and observational registries, providing tools that minimize documentation burden while ensuring high-quality data collection.
The institute uses a multi-modal, patent-pending Matthew Protocol™ combining biologics, pharmaceuticals, medical devices, specialized physical therapy, and holistic lifestyle interventions. It also integrates first-person expertise from the founder's own neurological trauma experience and partners with Cedars-Sinai for world-class clinical research.
Yes, 100% of net profits from apparel sales and all donations are directed exclusively toward funding research, patient treatment programs, and staffing for patient-facing roles, with transparent quarterly financial reporting.
Individuals can complete easy-to-use, HIPAA-compliant online forms available on the website to pre-qualify for clinical trials or observational registries targeting neurological trauma conditions.
While headquartered in El Segundo, California, the institute serves patients nationally across the United States and internationally, especially reaching military veterans, professional athletes, and disadvantaged populations.
No, in compliance with FDA regulations, adverse event reporting is provided free of charge to ensure patient safety and regulatory adherence.
The institute ensures comprehensive adherence to FDA, CURES Act, and global regulatory standards with clinical site coordination, trial outcome analysis, and rigorous data monitoring throughout the study lifecycle.
PINR offers trauma-informed, nonjudgmental medical and legal support, educational outreach, and assistance with healthcare navigation tailored to women survivors experiencing neurological trauma from abuse.
The institute provides end-to-end consulting, including eligibility assessments, submission preparation, and post-approval monitoring, aiming to accelerate the development and approval of biologics and pharmaceuticals targeting neurological disorders.
Holistic therapies such as diet, exercise, sleep hygiene, breathwork, and emotional regulation techniques are coordinated alongside biologic and pharmaceutical treatments to support neuro-regeneration and overall patient well-being.
The institute is led by founder and CEO Matthew Plummer, MBA, a neuroscience doctoral candidate with nearly three decades of experience in neuro-oncology and brain tumor treatment innovation, supported by a multidisciplinary leadership team including Cedars-Sinai-affiliated clinicians.
The institute commits to quarterly financial reporting, modest executive salaries, and strict vetting of donors to ensure funds are used transparently and ethically to support research and patient care.